ACAD vs TGTX
ACADIA Pharmaceuticals Inc · TG Therapeutics Inc
Relative return (rebased to 100)
Key stats
| Metric | ACAD | TGTX |
|---|---|---|
| Price | $25.39 | $55.75 |
| Market Cap | $4.35B | $8.53B |
| P/E | 11.12 | 19.08 |
| P/B | 3.48 | 14.64 |
| P/S | 4.06 | 13.85 |
| ROE | 31.3% | 76.7% |
| Net Margin | 36.5% | 72.6% |
| Gross Margin | 63.9% | — |
| Revenue Growth | 11.9% | 87.3% |
| Dividend Yield | — | — |
| EPS | $2.28 | $2.92 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.